OverviewSuggest Edit

Tubulis is a company that develops antibody drug conjugate assets. Its solutions are integrated with disease biology and address medical needs.

Latest Updates

Employees (est.) (Oct 2020)7
Cybersecurity ratingAMore

Key People/Management at Tubulis

Dominik Schumacher

Dominik Schumacher

Founder, CEO
Jonas Helma-Smets

Jonas Helma-Smets

Founder, CSO
Ingo Lehrke

Ingo Lehrke

Show more

Tubulis Financials and Metrics

Summary Metrics

Founding Date


Tubulis total Funding

$13.7 m

Tubulis latest funding size

$12.24 m

Time since last funding

3 months ago

Tubulis investors

Tubulis's latest funding round in July 2020 was reported to be $12.2 m. In total, Tubulis has raised $13.7 m
Show all financial metrics

Tubulis Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Tubulis Online and Social Media Presence

Embed Graph

Tubulis Frequently Asked Questions

  • When was Tubulis founded?

    Tubulis was founded in 2012.

  • Who are Tubulis key executives?

    Tubulis's key executives are Dominik Schumacher, Jonas Helma-Smets and Ingo Lehrke.

  • How many employees does Tubulis have?

    Tubulis has 7 employees.

  • Who are Tubulis competitors?

    Competitors of Tubulis include LifebankUSA, Braeburn Pharmaceuticals and NorthSea Therapeutics.